Cargando…
Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay
ADAM17 and its inhibitor TIMP3 are involved in nephropathy, but their role in diabetic kidney disease (DKD) is unclear. Diabetic Timp3(−/−) mice showed increased albuminuria, increased membrane thickness and mesangial expansion. Microarray profiling uncovered a significant reduction of Foxo1 express...
Autores principales: | Fiorentino, Loredana, Cavalera, Michele, Menini, Stefano, Marchetti, Valentina, Mavilio, Maria, Fabrizi, Marta, Conserva, Francesca, Casagrande, Viviana, Menghini, Rossella, Pontrelli, Paola, Arisi, Ivan, D'Onofrio, Mara, Lauro, Davide, Khokha, Rama, Accili, Domenico, Pugliese, Giuseppe, Gesualdo, Loreto, Lauro, Renato, Federici, Massimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
WILEY-VCH Verlag
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598083/ https://www.ncbi.nlm.nih.gov/pubmed/23401241 http://dx.doi.org/10.1002/emmm.201201475 |
Ejemplares similares
-
TIMP3 interplays with apelin to regulate cardiovascular metabolism in hypercholesterolemic mice
por: Stöhr, Robert, et al.
Publicado: (2015) -
TIMP3 Overexpression in Macrophages Protects From Insulin Resistance, Adipose Inflammation, and Nonalcoholic Fatty Liver Disease in Mice
por: Menghini, Rossella, et al.
Publicado: (2012) -
Restoration of renal TIMP3 levels via genetics and pharmacological approach prevents experimental diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021) -
Hepatocyte specific TIMP3 expression prevents diet dependent fatty liver disease and hepatocellular carcinoma
por: Casagrande, Viviana, et al.
Publicado: (2017) -
TIMP3 involvement and potentiality in the diagnosis, prognosis and treatment of diabetic nephropathy
por: Casagrande, Viviana, et al.
Publicado: (2021)